These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 37529276)

  • 1. Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study.
    Ettingshausen CE; Hermans C; Holme PA; Cid AR; Khair K; Oldenburg J; Négrier C; Botha J; Lelli A; Windyga J
    Ther Adv Hematol; 2023; 14():20406207231184323. PubMed ID: 37529276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of emicizumab for the treatment of hemophilia A.
    Yoneyama K; Schmitt C; Portron A; Kiialainen A; Kotani N; Jaminion F; Retout S; Adamkewicz JI
    Expert Rev Clin Pharmacol; 2023; 16(9):775-790. PubMed ID: 37529848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of recombinant factor VIII in adults with severe hemophilia A: fixed-sequence single-dose study of octocog alfa, rurioctocog alfa pegol, and efanesoctocog alfa.
    Lissitchkov T; Willemze A; Jan C; Zilberstein M; Katragadda S
    Res Pract Thromb Haemost; 2023 May; 7(4):100176. PubMed ID: 37538505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of bleeding event frequency on health-related quality of life and work productivity outcomes in a European cohort of adults with haemophilia A: insights from the CHESS II study.
    Young L; Chen Y; Alvir J; Burke T; Ferri Grazzi E; Winburn I
    Orphanet J Rare Dis; 2023 Aug; 18(1):227. PubMed ID: 37537683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-targeted gene therapy induces immune tolerance in hemophilia and beyond.
    Kumar S; Schroeder JA; Shi Q
    J Thromb Haemost; 2024 Jan; 22(1):23-34. PubMed ID: 37558132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of rFIXFc versus N9-GP Prophylaxis in Patients with Hemophilia B: Matching-Adjusted Indirect Comparison of B-LONG and PARADIGM 2 Trials.
    Mancuso ME; Eriksson D; Falk A; Hakimi Z; Wojciechowski P; Wdowiak M; Klamroth R
    J Blood Med; 2023; 14():427-434. PubMed ID: 37534261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of joint status using ultrasound assessments and Haemophilia Joint Health Score 2.1 in children with haemophilia.
    Li Y; Wang F; Pan C; Zhang J; Zhang Q; Ban L; Song L; Wang J; He Z; Zeng X; Tang D; Liu Y
    Front Med (Lausanne); 2023; 10():1193830. PubMed ID: 37534313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bispecific antibodies mimicking factor VIII in hemophilia A: converting innovation to an essential medicine.
    Hermans C; Pierce GF
    Res Pract Thromb Haemost; 2023 May; 7(4):100173. PubMed ID: 37538493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VIII inhibitors in hemophilia A treated with emicizumab: longitudinal follow-up of outcomes.
    Levy-Mendelovich S; Atia N; Budnik I; Barg AA; Avishai E; Cohen O; Brutman-Barazani T; Livnat T; Kenet G
    Res Pract Thromb Haemost; 2023 May; 7(4):100278. PubMed ID: 37538499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus with acquired hemophilia A: A case report and literature review.
    Ye M; Deng R; Shen F; Hou Z; Lin L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):789-794. PubMed ID: 37539582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awareness of individual goals, preferences, and priorities of persons with severe congenital haemophilia A for a tailored shared decision-making approach to liver-directed gene therapy. A practical guideline.
    Di Minno G; Spadarella G; Maldonato NM; De Lucia N; Castaman G; De Cristofaro R; Santoro C; Peyvandi F; Borrelli A; Lupi A; Follino M; Guerrino G; Morisco F; Di Minno M
    Blood Rev; 2023 Nov; 62():101118. PubMed ID: 37544828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII.
    Hillarp A; Holme PA; Wåland EP; Le MS; Henriksson CE; Tjønnfjord GE; Måseide RJ
    J Thromb Haemost; 2023 Oct; 21(10):2771-2775. PubMed ID: 37543216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding management: rFVIIIFc in hemophilia A and liver transplantation.
    Grottke O; Rieg A; Ulmer F; Hein M
    Anaesthesiologie; 2023 Dec; 72(12):883-886. PubMed ID: 37563315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Severe Hemophilia A: Low-Dose Prophylaxis vs. On-Demand Treatment.
    Munawar Ali R; Abid M; Zafar S; Ali MS; Nadeem R; Ahmed R; Borhany M
    Cureus; 2023 Jul; 15(7):e41410. PubMed ID: 37546069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasciotomy on a female patient with acquired factor VIII: A case report and literature review of management.
    Lovell K; Peters B; Pasli M; Kennedy K; Liles D; Pories W
    Clin Case Rep; 2023 Aug; 11(8):e7773. PubMed ID: 37546159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of Bionano-DNA Full-Length Optical Mapping Technology in Genetic Diagnosis of Hemophilia A Carriers].
    Niu SY; Liu MY; Ding ZX; Xie JD; Jiang AR; Yu ZQ; Wang ZY; Ruan CG; Xia LJ; Jiang M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):1211-1216. PubMed ID: 37551500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of PK-guided prophylaxis on clinical outcomes and FVIII consumption for patients with moderate to severe Haemophilia A.
    Young G; Callaghan MU; Balasa V; Soni A; Ahuja S; Roberts JC; Simpson ML; Kizilocak H; Frick A; Mokdad AG; Xing S; Caicedo J
    Haemophilia; 2023 Sep; 29(5):1234-1242. PubMed ID: 37553998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frailty and haemophilia; speaking the language of geriatricians.
    Sangha G; Obeidalla A; Taylor S; McKeown W; Shapiro S
    Haemophilia; 2023 Sep; 29(5):1371-1375. PubMed ID: 37556315
    [No Abstract]   [Full Text] [Related]  

  • 19. Adherence to hemophilia patients with prophylaxis: Veritas-Pro and psychometric properties adapted to Turkish.
    Mehrekula Demirci Z; Demiral Yilmaz N; Bulbul H; Keklik Karadag F; Atilla FD; Saydam G; Sahin F
    PLoS One; 2023; 18(8):e0288625. PubMed ID: 37556439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irregularities of Coagulation in Hypertension.
    Rafaqat S; Khalid A; Riaz S; Rafaqat S
    Curr Hypertens Rep; 2023 Oct; 25(10):271-286. PubMed ID: 37561240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.